Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces that all resolutions put to shareholders at the Company’s Annual General Meeting held earlier today were duly passed.
Continue readingPoolbeg featured in the @MorningstarInc following yesterdays announcement on the completion of build 7 optimisation of our #AI model for RSV #data, the first time AI used to model #RSV with complete longitudinal #disease data. Link below to read in full: https://www.morningstar.co.uk/uk/news/AN_1656323268845373200/poolbeg-pharma-ai-model-of-respiratory-syncytial-virus-starts-analysis.aspx
Continue readingThe Board of Vela (AIM:VELA) has become aware that the announcement that it made at 7.00 a.m. on Tuesday 14 June 2022 has been misinterpreted in some quarters and is therefore issuing this further update. The earlier announcement stated that a placing letter had been signed on behalf of Vela without the authority of the Vela Board. Vela wishes to clarify that the broker referred to in the announcement as ‘the Company’s own broker’ was…
Continue readingKavango Resources plc (LSE:KAV), the exploration company targeting the discovery of world-class mineral deposits in Botswana, is pleased to provide an operational update. Highlights Ø Recruitment of new senior commercial and exploration personnel – Tiyapo (Tipps) Ngwisanyi is the former and founding CEO of the Government owned Botswana Geoscience Institute. Tipps has joined the Company as Managing Director of Kavango Minerals (Pty) Ltd – John Lauderdale is a Chartered Geologist and seasoned exploration professional, who has run large-scale exploration programmes…
Continue reading
